Treatment of GERD in Pregnancy
For pregnant women with GERD, begin with lifestyle modifications and dietary changes, then escalate to calcium-containing antacids, followed by H2-receptor antagonists (ranitidine preferred), and reserve proton pump inhibitors (lansoprazole preferred) only for severe, intractable symptoms after the first trimester. 1, 2
Step-Up Treatment Algorithm
First-Line: Lifestyle and Dietary Modifications
- Reduce intake of spicy, fatty, acidic, and fried foods 3
- Consume small, frequent meals rather than large portions 3
- Identify and avoid specific food triggers, particularly those with strong odors 3
- These modifications should be attempted first as GERD affects 30-90% of pregnant women, with symptoms typically beginning in the first trimester and progressing throughout pregnancy 3, 1
Second-Line: Antacids and Mucosal Protectants
- Calcium-containing antacids are the preferred first-line medical therapy due to their safety profile and minimal systemic absorption 1, 4
- Magnesium-based antacids can also be used, particularly in patients with preeclampsia 4
- Sucralfate (1g oral tablet, 3 times daily) is an excellent option if symptoms persist with antacids alone, as it has minimal systemic absorption and is considered safe 1, 4
- Alginic acid can be used as an alternative mucosal protectant 4
Third-Line: H2-Receptor Antagonists
- Ranitidine is the preferred H2-receptor antagonist due to its documented efficacy and safety profile throughout pregnancy, including the first trimester 5, 4
- Famotidine is also considered safe, with FDA labeling showing efficacy for GERD symptoms and erosive esophagitis 6
- Nizatidine should be avoided during pregnancy 2
- H2-receptor antagonists should be initiated when symptoms persist despite antacids and sucralfate 1
Fourth-Line: Proton Pump Inhibitors (Reserved for Severe Cases)
- PPIs should be reserved exclusively for women with intractable symptoms or complicated reflux disease that has not responded to the above therapies 5, 2
- Lansoprazole is the preferred PPI based on animal teratogenicity studies and case reports demonstrating safety in human pregnancies 5, 2
- Lansoprazole has demonstrated efficacy in healing erosive esophagitis, with 93-95% healing rates at 6 weeks for the 30mg daily dose 7
- Omeprazole should be avoided during pregnancy 4
- PPIs should not be used during the first trimester except in rare, severe intractable cases, and only after careful consideration of the benefit-harm ratio for both mother and fetus 4, 2
Critical Safety Considerations
Timing and Progression
- Early treatment is essential to prevent progression to hyperemesis gravidarum 3
- The physiologic basis for GERD in pregnancy is primarily hormonal: progesterone causes relaxation of the lower esophageal sphincter, facilitating gastroesophageal reflux 3, 5
- Approximately 25% of pregnant women experience daily heartburn 1
Medications to Avoid
- Metoclopramide and ondansetron should be avoided before 10 weeks of gestation due to possible teratogenic risks 3
- Nizatidine should not be used during pregnancy 2
- Omeprazole is not recommended as the PPI of choice 4
Common Pitfalls
- Do not jump directly to PPIs without attempting the step-up approach, as serious reflux complications during pregnancy are rare and most cases respond to conservative measures 5
- Do not withhold necessary treatment due to pregnancy concerns, as inadequately controlled GERD can significantly impact maternal quality of life and potentially lead to more serious complications 1
- Ensure adequate counseling about the benefit-risk ratio when escalating to systemic therapies, particularly PPIs 2
- Use the least possible amount of systemic medication needed to ameliorate symptoms 2